Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Mangoceuticals, Inc. ( (MGRX) ) has issued an announcement.
Mangoceuticals, Inc. has acquired a patent for mushroom-derived nutraceutical compositions, enhancing its intellectual property portfolio. This strategic move aims to capitalize on the growing global nutraceutical market by developing innovative wellness products leveraging the health benefits of functional mushrooms. The company plans to introduce a range of dietary supplements and functional foods, emphasizing immune support, cognitive enhancement, stress management, and weight control. This acquisition aligns with Mangoceuticals’ mission to offer cutting-edge health solutions, potentially strengthening its market position and expanding its product line.
More about Mangoceuticals, Inc.
Mangoceuticals, Inc., also known as MangoRx, operates in the health and wellness industry, focusing primarily on men’s health products. The company offers services through a secure telemedicine platform, with products targeting erectile dysfunction, hair growth, hormone replacement therapies, and weight management.
YTD Price Performance: -40.96%
Average Trading Volume: 379,430
Technical Sentiment Consensus Rating: Buy
For a thorough assessment of MGRX stock, go to TipRanks’ Stock Analysis page.
